Key Points The Trump administration is reportedly considering covering GLP-1 weight loss drugs under Medicare and Medicaid. Price is a big obstacle for people wanting to take GLP-1 drugs without insurance, as the drugs can have list prices of $1,000 per month or higher. GLP-1 drugs have been linked to other health benefits besides just weight loss. 10 stocks we like better than Novo Nordisk › Two of the hottest healthcare stocks in recent years have been Novo Nordisk (NYSE: NVO) and Eli Lilly (NY ...